C12N 5/0657
Cardiomyocytes
Official title: {Cardiomyocytes; Heart cells}
C12N5/0657 (Cardiomyocytes) appears on 590 US grants and 1,241 published applications in this corpus.
Search patents in C12N- Granted patents
- 590
- Published applications
- 1,241
- Assignees
- 509
- Inventors
- 1,995
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 3 |
| 2002 | 4 | 8 |
| 2003 | 1 | 15 |
| 2004 | 6 | 19 |
| 2005 | 4 | 24 |
| 2006 | 4 | 28 |
| 2007 | 8 | 29 |
| 2008 | 4 | 28 |
| 2009 | 8 | 37 |
| 2010 | 10 | 35 |
| 2011 | 12 | 34 |
| 2012 | 19 | 54 |
| 2013 | 19 | 53 |
| 2014 | 28 | 46 |
| 2015 | 36 | 50 |
| 2016 | 37 | 82 |
| 2017 | 41 | 61 |
| 2018 | 52 | 62 |
| 2019 | 33 | 75 |
| 2020 | 45 | 94 |
| 2021 | 31 | 75 |
| 2022 | 35 | 75 |
| 2023 | 39 | 88 |
| 2024 | 35 | 60 |
| 2025 | 36 | 65 |
| 2026 | 30 | 41 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Gene-therapy vectors for treating cardiomyopathy29 Sep 2026US 12,747,453 B2
- Pluripotent stem cell-derived heart organoid22 Sep 2026US 12,742,157 B2Board of Trustees of Michigan State University
- Gene-therapy vectors for treating cardiomyopathy22 Sep 2026US 12,742,181 B2
- KLF induced cardiomyogenesis8 Sep 2026US 12,729,226 B2National Cerebral and Cardiovascular Center
- Methods for the production of cardiac fibroblasts25 Aug 2026US 12,714,728 B2FUJIFILM Cellular Dynamics, Inc.
- Protocol for maturation of 3D engineered heart tissue8 Oct 2026US 2026/0308527 A1
- Universal treatment of down syndrome1 Oct 2026US 2026/0294978 A1DEI Biopharma
- Differentiation of ipscs in bioreactors24 Sep 2026US 2026/0286309 A1Repairon GmbH
- Maturation medium compositions and methods for human heart organoid maturation17 Sep 2026US 2026/0275292 A1Board of Trustees of Michigan State University
- Use of Chymopapain in Cell Detachment17 Sep 2026US 2026/0275293 A1Novo Nordisk Pharmatech A/S
Most cited
By later US patents
- Transplants for myocardial scars141US 6,099,832 AGenzyme Corporation · 2000
- Method of transluminal application of myogenic cells for repair or replacement of heart tissue88US 6,805,860 B12004
- Non-human mammal having a graft and methods of delivering protein to myocardial tissue84US 5,602,301 AIndiana University Foundation · 1997
- Myocardial grafts and cellular compositions78US 6,015,671 AIndiana University Foundation · 2000
- Cardiac muscle regeneration using mesenchymal stem cells78US 7,514,074 B2Osiris Therapeutics, Inc. · 2009